Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to standa…

Continue in Briflio to read, react, comment, and share.